CN105616792A - Medicine for treating rheumatic bone pain - Google Patents

Medicine for treating rheumatic bone pain Download PDF

Info

Publication number
CN105616792A
CN105616792A CN201610053784.3A CN201610053784A CN105616792A CN 105616792 A CN105616792 A CN 105616792A CN 201610053784 A CN201610053784 A CN 201610053784A CN 105616792 A CN105616792 A CN 105616792A
Authority
CN
China
Prior art keywords
medicine
parts
radix
patients
bone pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610053784.3A
Other languages
Chinese (zh)
Inventor
彭毅
鄢国祥
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GUIZHOU TONGREN FANKANG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Original Assignee
GUIZHOU TONGREN FANKANG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GUIZHOU TONGREN FANKANG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd filed Critical GUIZHOU TONGREN FANKANG BIOLOGICAL SCIENCE & TECHNOLOGY Co Ltd
Priority to CN201610053784.3A priority Critical patent/CN105616792A/en
Publication of CN105616792A publication Critical patent/CN105616792A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A61K36/8884Arisaema, e.g. Jack in the pulpit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125Camphor; Nuclear substituted derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/646Arachnids, e.g. spiders, scorpions, ticks or mites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/237Notopterygium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/56Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716Clematis (leather flower)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Abstract

The invention relates to the technical field of medicines for treating rheumatic bone pain and in particular relates to a medicine for treating rheumatic bone pain. Clematis root, arisaema cum bile, prepared nux vomica, ephedra, lycopodium clavatum, wikstroemia indica, notopterygium root, pubescent angelica root, scorpions, borneol and camphor are proportioned and designed to generate synergistic effects, so that medical effects are mutually enhanced, the effect of the medicine on treating rheumatic diseases is improved, and the absorbing capacity of patients to the medicine is enhanced; especially, the medicines including camphor and the like with the effect of local anaesthesia are mixed and act with other traditional Chinese medicine raw materials, so that the narcotic treatment on the patients is effectively executed, the pain of the patients is reduced, and the quality of life of the patients is improved; and other medicines with the effects of stopping pain, diminishing inflammation, clearing internal heat, relaxing muscles and tendons, promoting blood circulation, removing dampness and eliminating swelling are mixed, so that after the preparation is sprayed on the affected parts of the patients, the blood circulation of the patients can be promoted, the absorption rate to the medicine can be enhanced, the cure rate of the patients can be increased, and the effective rate can reach 91.3%.

Description

One treats rheumatic bone pain medicine
Technical field
The present invention relates to rheumatic bone pain practical technique field, especially one treats rheumatic bone pain medicine.
Background technology
Rheumatismal obstinate, recurrent exerbation so that patient enjoys and decocts, while showing effect along with rheumatism, it is it would appear that the bone generation pain of intra articular so that the orthobiosis of patient is affected so that the life of patient is seriously inconvenient; Further, the report according to Center for Disease Control (CDC) of the world, rheumatism is the difficult miscellaneous diseases having a kind of serious threat human health after cancer. According to statistics, annual because the medical expense of rheumatism payment is up to several hundred million units, and present the trend of increase year by year; Further, after the treatment incuring loss through delay rheumatism, it directly threatens heart, some patients there will be joint and disables and viscera function exhaustion, and according to data statistics, because the patient that rheumatism causes paralysis reaches about 50%.
In prior art, medicine for rheumatism has Western medicine and Chinese medicine, western medicine instant effect, but its index is not effected a permanent cure so that rheumatism is after stopping using Western medicine, and it will recur, and side effect is bigger, the disease easily causing other produces, and such as organs such as injured nerve system, Liver and kidney, causes endocrine disturbance, gastrorrhagia etc. Along with being progressively exploited of Chinese medicine, Chinese medicine obtains the favor of people for the treatment of disease, for this, prior art also occur in that substantial amounts of about the group of formula for the treatment of by Chinese herbs rheumatism, preparation etc., but it is single due to curative effect, effective slowly, cure rate is low, the defects such as treatment cycle length so that patient pain's sense is extended; Given this, prior art occurring in that, substantial amounts of be the medicine that preparation of raw material becomes the treatment disease such as rheumatism, rheumatoid about Chinese crude drug again, the medicine obtained can be reached, and treatment time is short, cure rate is higher, alleviate the purpose of patient suffering, if the patent No. is 200410004755.5 " a kind of Chinese medicine compositions treating rheumatism and rheumatoid arthritis " etc.
However, medication is ached for rheumatic bone and becomes the long-term direction to Chinese medicine composition research, and in prior art, any being related to is not had to carry out after proportioning combines, being applied to the report in the treatment field of rheumatism, rheumatoid disease as material composition using Radix Clematidis, Arisaema Cum Bile, Semen Strychni (processed), Herba Ephedrae, Herba Lycopodii, Radix Wikstroemae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Scorpio, Borneolum Syntheticum, Camphora yet.
Summary of the invention
In order to solve the above-mentioned technical problem existed in prior art, the present invention provides one to treat rheumatic bone pain medicine.
It is achieved particular by techniques below scheme:
One treat rheumatic bone pain medicine, its material composition with parts by weight be Radix Clematidis 25-35 part, Arisaema Cum Bile 15-25 part, Semen Strychni (processed) 7-12 part, Herba Ephedrae 7-12 part, Herba Lycopodii 15-25 part, Radix Wikstroemae 15-25 part, Rhizoma Et Radix Notopterygii 15-25 part, Radix Angelicae Pubescentis 15-25 part, Scorpio 7-12 part, Borneolum Syntheticum 4-6 part, Camphora 4-6 part.
Described material composition with parts by weight be Radix Clematidis 30 parts, Arisaema Cum Bile 20 parts, Semen Strychni (processed) 10 parts, 10 parts of Herba Ephedrae, Herba Lycopodii 20 parts, Radix Wikstroemae 20 parts, Rhizoma Et Radix Notopterygii 20 parts, Radix Angelicae Pubescentis 20 parts, Scorpio 10 parts, Borneolum Syntheticum 5 parts, Camphora 5 parts.
Described material composition also includes ethanol.
Described medicine, it is the one in liniment, spray.
Described medicine, the formula of its material composition is to prepare 1L medicinal liquid, and its proportioning is: Radix Clematidis 30g, Arisaema Cum Bile 20g, Semen Strychni (processed) 10g, Herba Ephedrae 10g, Herba Lycopodii 20g, Radix Wikstroemae 20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, Scorpio 10g, Borneolum Syntheticum 5g, Camphora 5g, appropriate amount of ethanol.
Described ethanol, its consumption is the 50-75% accounting for medicine liquid volume in 1L medicinal liquid.
Above-mentioned component can be that crude drug carries out process of being used as medicine, or their any extract is used as medicine; Can be conventionally, the Chinese medicine composition of the present invention be prepared into suitable preparation, such as liniment, spray etc. After each raw medicinal material being ground, mix and is added ethanol reagent allotment, the liniment of preparation; Can also be, after each raw medicinal material is carried out alcohol extracting-water precipitating or water extract-alcohol precipitation, spray etc. is prepared in its concentration.
The Radix Clematidis that the present invention adopts, its can wind-damp dispelling, diuresis, stimulate the menstrual flow, ease pain, control that wind and cold is damp and hot, migraine, jaundice edema, the hard larynx of fishbone, waist knee joint legs and feet cold type of pain; Arisaema Cum Bile, it has a clearing away fire and eliminating phlegm, relieving convulsion fixed chronic, control middle wind-phlegm fan, infantile convulsion epilepsy, phlegm-fire is breathed heavily and is coughed, phlegm-accumulating vertigo; Semen Strychni (processed) has promoting blood circulation to remove obstruction in the collateral, relaxing muscles and tendons to promote blood circulation, effect of cold expelling dredging collateral, for mammary gland tumor, and ulcer sore pain has good curative effect; Herba Ephedrae contributes to dissipation edema, dispersing wind and cold; Herba Lycopodii has expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral; Radix Wikstroemae has heat-clearing and toxic substances removing, and eliminating stagnation is relieved oedema or abdominal distension through diuresis or purgation effect; For cough due to lung-heat, mumps, scrofula, rheumatic arthralgia, furuncle toxic swelling, edema abdominal distention; Rhizoma Et Radix Notopterygii have can relieving the exterior syndrome by diaphoresis, again can effect of wind-damp dispelling and pain relieving; Radix Angelicae Pubescentis has expelling wind and removing dampness, arthralgia aggravated by cold pain relieving; Scorpio has endogenous wind stopping spasmolytic, removing obstruction in the collateral to relieve pain, effect of dispersing pathogen accumulation; Borneolum Syntheticum has refreshment of having one's ideas straightened out, and heat clearing away dissipates effect of poison; Camphora has analgesia, antipruritic, slight local anaesthesia effect.
Above-mentioned Chinese prescription has and the joints such as human body neck, shoulder, arm, waist, lower limb or muscle, muscles and bones, the soft tissue pain discomfort caused such as tired, impaired is had expelling wind and removing dampness, releases the function of arthralgia pain, relaxing muscles and tendons bone strengthening, warming YANG to expel cold, removing obstruction in the collateral to relieve pain. Can adapt in various rheumatism, rheumatoid disease, arthritis, amyotrophy and the disease such as numb limbs and tense tendons, bone pain.
And find through the Chinese medicine of the present invention is carried out research, its effective ingredient can block each link of the morbidity of rheumatism fast and effectively, it is to avoid over the course for the treatment of, rheumatism converts, and the formation of immune complex can be suppressed, reduce the opposing to this medicine of patient's human body; The blood circulation of local is improved by the medicine after being joined by group, reduces capillary permeability, alleviates and diminish inflammation, reach strengthening the tendons and bones, effect of liver and kidney tonifying, it is to avoid joint deformity, diminish inflammation and dysfunction, reach the purpose of radical cure rheumatism.
Compared with prior art, the technique effect of the present invention is embodied in:
After Radix Clematidis, Arisaema Cum Bile, Semen Strychni (processed), Herba Ephedrae, Herba Lycopodii, Radix Wikstroemae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Scorpio, Borneolum Syntheticum, Camphora are carried out proportion design, make it that mutually collaborative effect occur, each drug effect is made to obtain mutual enhancing, improve the medicine therapeutic efficiency to rheumatism, and the absorbability of medicine is strengthened by patient; Especially will there is the medicament mixed such as the Camphora of local anesthesia as wherein so that after itself and other raw material of Chinese medicine are had an effect, it is possible to effectively patient is carried out narcoticness treatment, reduce the misery of patient, improve the quality of life of patient; Have in conjunction with other relieve the pain, antiinflammatory, relieve inflammation or internal heat, heat clearing away, relaxing muscles and tendons to promote blood circulation, dehumidifying detumescence medicine mix, after making to be sprayed on the preparation of preparation the affected part of patient, the blood circulation of patient can be promoted, strengthen the absorbance to medicine, improve the cure rate of patient so that effective percentage reaches 100%.
The researcher of the present invention finds through research, and it is after the clinical treatment rheumatism of hundreds of examples, it is carried out statistics and draws:
The effective percentage of rheumatism has been reached 91.3% by it, and its cure rate reaches more than 87.5%, and, for suffer from the patient that the rheumatism time do not grow treat time, it is after painting puts 3-5 days on the skin, and it is cured substantially, and observes through following the tracks of, it has no any rebound phenomenon in 1 year, it is achieved that the purpose that the light patient clinical of rheumatism is cured; Meanwhile, severe patient also carrying out the tracking observation experiment of clinical treatment, its result is: after medication 3-5 days, and its inflammation eliminates, and the swelling of each diseased region, fiber crops acid phenomenon are eased; After proceeding medication 10-15 days, the tissue of its breakage, cell are all repaired, and the swelling of each diseased region, fiber crops acid phenomenon eliminate, and limb activity is freely; After continuing medication 5 days, the blood circulation of its diseased region is vigorous, and immunity improves, and realizes the effect of clinical cure.
Above-mentioned severe patient refers to that the ill cycle is longer, rheumatalgia distance, completely can not the patient of orthobiosis, and severe patient is carried out the observation after medication healing, there is not any rebound phenomenon in 1 year in it so that rheumatism is cured thoroughly, the misery of patient alleviated.
The present invention is after the raw material of Chinese medicine of above-mentioned formula is prepared into liniment or spray, by its affected part according to coating or be sprayed on affected part, and medication 2-5 time every day.
What the present invention was optimum is wherein carry out proportion design as material composition also by being added by ethanol, make ethanol as after solvent, leach out by the effective ingredient in traditional Chinese medicinal material raw materials composition, and ethanol can effectively promote skin absorption, improve coating or be sprayed on the medicine in affected part and carry out absorbance so that medicine quickly can infiltrate through site of disease through skin histology, reaches the purpose to patient's healing, improve cure rate, reduce the misery of patient; And can blood circulation promoting, improve the material effective component coverage rate to patient affected part, block rheumatism morbidity links, improve cure rate.
Detailed description of the invention
Below in conjunction with specific embodiment technical scheme done further restriction, but the scope claimed is not only limited to the description made.
Embodiment 1
One treats rheumatic bone pain medicine, and its material composition is Radix Clematidis 25g, Arisaema Cum Bile 15g, Semen Strychni (processed) 7g, Herba Ephedrae 7g, Herba Lycopodii 15g, Radix Wikstroemae 15g, Rhizoma Et Radix Notopterygii 15g, Radix Angelicae Pubescentis 15g, Scorpio 7g, Borneolum Syntheticum 4g, Camphora 4g by weight. By its conventionally technique prepare into liniment, it adopts alcohol extracting method by the extracts active ingredients in raw material of Chinese medicine out.
Embodiment 2
One treats rheumatic bone pain medicine, and its material composition is Radix Clematidis 35g, Arisaema Cum Bile 25g, Semen Strychni (processed) 12g, Herba Ephedrae 12g, Herba Lycopodii 25g, Radix Wikstroemae 25g, Rhizoma Et Radix Notopterygii 25g, Radix Angelicae Pubescentis 25g, Scorpio 12g, Borneolum Syntheticum 6g, Camphora 6g by weight. Conventionally technique, is carried out water and is carried or after alcohol extraction, be prepared into spray.
Embodiment 3
One treats rheumatic bone pain medicine, material composition is Radix Clematidis 30g, Arisaema Cum Bile 20g, Semen Strychni (processed) 10g, Herba Ephedrae 10g, Herba Lycopodii 20g, Radix Wikstroemae 20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, Scorpio 10g, Borneolum Syntheticum 5g, Camphora 5g by weight, and after being ground into powder, conventionally technique, adds appropriate ethanol adjustment and prepares into liniment.
Embodiment 4
Treatment rheumatic bone pain medicine, by the formula of its material composition to prepare 1L medicinal liquid, its proportioning is: Radix Clematidis 30g, Arisaema Cum Bile 20g, Semen Strychni (processed) 10g, Herba Ephedrae 10g, Herba Lycopodii 20g, Radix Wikstroemae 20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, Scorpio 10g, Borneolum Syntheticum 5g, Camphora 5g, ethanol, and its consumption is account for medicine liquid volume 65%.
Embodiment 5
Treatment rheumatic bone pain medicine, by the formula of its material composition to prepare 1L medicinal liquid, its proportioning is: Radix Clematidis 30g, Arisaema Cum Bile 20g, Semen Strychni (processed) 10g, Herba Ephedrae 10g, Herba Lycopodii 20g, Radix Wikstroemae 20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, Scorpio 10g, Borneolum Syntheticum 5g, Camphora 5g, ethanol, and its consumption is account for medicine liquid volume 50%.
Embodiment 6
On the basis of embodiment 5, its ethanol, its consumption is account for medicine liquid volume 75%.

Claims (6)

1. a treatment rheumatic bone pain medicine, it is characterized in that, its material composition with parts by weight be Radix Clematidis 25-35 part, Arisaema Cum Bile 15-25 part, Semen Strychni (processed) 7-12 part, Herba Ephedrae 7-12 part, Herba Lycopodii 15-25 part, Radix Wikstroemae 15-25 part, Rhizoma Et Radix Notopterygii 15-25 part, Radix Angelicae Pubescentis 15-25 part, Scorpio 7-12 part, Borneolum Syntheticum 4-6 part, Camphora 4-6 part.
2. treatment rheumatic bone pain medicine as claimed in claim 1, it is characterized in that, described material composition with parts by weight be Radix Clematidis 30 parts, Arisaema Cum Bile 20 parts, Semen Strychni (processed) 10 parts, 10 parts of Herba Ephedrae, Herba Lycopodii 20 parts, Radix Wikstroemae 20 parts, Rhizoma Et Radix Notopterygii 20 parts, Radix Angelicae Pubescentis 20 parts, Scorpio 10 parts, Borneolum Syntheticum 5 parts, Camphora 5 parts.
3. treatment rheumatic bone pain medicine as claimed in claim 1 or 2, it is characterised in that described material composition also includes ethanol.
4. treatment rheumatic bone pain medicine as claimed in claim 1 or 2, it is characterised in that described medicine, it is the one in liniment, spray.
5. the treatment rheumatic bone pain medicine as described in any one of claim 1-4, it is characterized in that, described medicine, the formula of its material composition is to prepare 1L medicinal liquid, and its proportioning is: Radix Clematidis 30g, Arisaema Cum Bile 20g, Semen Strychni (processed) 10g, Herba Ephedrae 10g, Herba Lycopodii 20g, Radix Wikstroemae 20g, Rhizoma Et Radix Notopterygii 20g, Radix Angelicae Pubescentis 20g, Scorpio 10g, Borneolum Syntheticum 5g, Camphora 5g, appropriate amount of ethanol.
6. treatment rheumatic bone pain medicine as claimed in claim 5, it is characterised in that described ethanol, its consumption is the 50-75% accounting for medicine liquid volume in 1L medicinal liquid.
CN201610053784.3A 2016-01-27 2016-01-27 Medicine for treating rheumatic bone pain Pending CN105616792A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610053784.3A CN105616792A (en) 2016-01-27 2016-01-27 Medicine for treating rheumatic bone pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610053784.3A CN105616792A (en) 2016-01-27 2016-01-27 Medicine for treating rheumatic bone pain

Publications (1)

Publication Number Publication Date
CN105616792A true CN105616792A (en) 2016-06-01

Family

ID=56032403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610053784.3A Pending CN105616792A (en) 2016-01-27 2016-01-27 Medicine for treating rheumatic bone pain

Country Status (1)

Country Link
CN (1) CN105616792A (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203808A (en) * 1998-07-30 1999-01-06 潘二纵 Medicine for strengthening sinew and bone and its preparing method
CN1364630A (en) * 2002-01-15 2002-08-21 吕劲松 Rheumatic pain killing medicine powder
CN1879856A (en) * 2006-05-01 2006-12-20 杨树民 An externally applied ointment
CN101066348A (en) * 2007-06-06 2007-11-07 钱智 Medicine for treating osteoarthrosis caused by wind, cold and damp and its prepn
CN101890150A (en) * 2010-03-20 2010-11-24 李志刚 Novel and special Likexiao
CN102727833A (en) * 2012-07-12 2012-10-17 李琦 Plaster for treating rheumatoid bone disease
CN104398718A (en) * 2014-11-06 2015-03-11 候纪海 Plaster for treating pains in neck, shoulder, waist and legs, and making method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203808A (en) * 1998-07-30 1999-01-06 潘二纵 Medicine for strengthening sinew and bone and its preparing method
CN1364630A (en) * 2002-01-15 2002-08-21 吕劲松 Rheumatic pain killing medicine powder
CN1879856A (en) * 2006-05-01 2006-12-20 杨树民 An externally applied ointment
CN101066348A (en) * 2007-06-06 2007-11-07 钱智 Medicine for treating osteoarthrosis caused by wind, cold and damp and its prepn
CN101890150A (en) * 2010-03-20 2010-11-24 李志刚 Novel and special Likexiao
CN102727833A (en) * 2012-07-12 2012-10-17 李琦 Plaster for treating rheumatoid bone disease
CN104398718A (en) * 2014-11-06 2015-03-11 候纪海 Plaster for treating pains in neck, shoulder, waist and legs, and making method thereof

Similar Documents

Publication Publication Date Title
CN107050402A (en) Plaster for treating rheumatic ostealgia and preparation method thereof
CN111840383A (en) Targeted spray moxibustion composition for treating rheumatic arthritis and preparation and use methods thereof
CN104524208A (en) Medicament for treatment of sciatica and preparation method
CN105056042A (en) Medicinal liquor for treating traumatic injuries
CN102793888B (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN111297998A (en) Pain-relieving liquid
CN105616792A (en) Medicine for treating rheumatic bone pain
CN104055973B (en) Treatment rheumatism bone disease, the Chinese medicinal liniment of arthralgia
CN107007714A (en) It is a kind of that there is the exterior-applied medical wine for promoting poroma nucleus formation
CN105343670A (en) Traditional Chinese medicine for treating knee osteoarthritis
CN111358915A (en) Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof
CN105641282B (en) External traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain
CN110448605A (en) A kind of topical composition that treating rheumatism bone disease and preparation method
CN110038101A (en) A kind of Chinese medicine is dispelled antipruritic external preparation of pain and preparation method thereof
CN109289020A (en) Chinese medicine acupoint magnetic heat orients transdermal
CN116173160B (en) External swelling-diminishing pain-relieving formula and application thereof
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN106853240A (en) It is a kind of effectively to treat external application decoction medicine of osteopathy and preparation method thereof
CN106728969A (en) Kidney tonifying pain-relieving powder is trembled with fear plaster
CN105412395A (en) Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof
CN105343771A (en) Novel traditional Chinese medicine for treating cervical and lumbar degenerative disease and preparation technology thereof
CN104825568A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis and preparation method thereof
CN105250923A (en) Traditional Chinese medicine composition for treating rheumatism and rheumatoid
CN116173160A (en) External swelling-diminishing pain-relieving formula and application thereof
CN102579732B (en) Ointment for treating femoral head necrosis and preparation method of ointment

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160601